| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/23/2002 | US6423044 Disposable article having bodily waste isolation device |
| 07/23/2002 | US6423001 Method and apparatus for signal transmission and detection using a contact device |
| 07/23/2002 | US6422737 Liquid sample cylinder with integral mixing pump |
| 07/23/2002 | US6422465 Bar code gasoline blending |
| 07/23/2002 | US6422090 Apparatus for a thermodynamic material testing system that produces very large strains in crystalline metallic specimens and accompanying methods for use therein |
| 07/23/2002 | US6422071 Stone pecking machine |
| 07/23/2002 | US6422068 Test rig and particulate deposit and cleaning evaluation processes using the same |
| 07/23/2002 | US6422067 Slurry useful for wire-saw slicing and evaluation of slurry |
| 07/23/2002 | US6422066 Optical fiber detector; dye well; silicone membrane |
| 07/23/2002 | US6422065 Method for testing a cell sample |
| 07/23/2002 | US6422061 Apparatus, systems and methods for detecting and transmitting sensory data over a computer network |
| 07/23/2002 | CA2369183A1 Means and methods for treatment evaluation |
| 07/23/2002 | CA2368791A1 Medicament for the protection against thrombotic diseases |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2303598C Tandem immuno-assay for cancer |
| 07/23/2002 | CA2168440C Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/23/2002 | CA2074720C Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 07/23/2002 | CA2073504C Device and method for conducting immunoassays |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/23/2002 | CA2059060C Cell surface receptor complimentation |
| 07/23/2002 | CA2027451C Reagent for measurement of leukocytes and hemoglobin in blood |
| 07/18/2002 | WO2002056489A2 Local oscillator leakage control in direct conversion processes |
| 07/18/2002 | WO2002056311A2 Optical disc analysis system including related methods for biological and medical imaging |
| 07/18/2002 | WO2002056259A1 Three-dimensional verification supporting apparatus, three-dimensional structure verification method, record medium, and program |
| 07/18/2002 | WO2002056236A2 Classification of polypeptides by ligand geometry and related methods |
| 07/18/2002 | WO2002056057A2 Dotted micro-array data extraction method |
| 07/18/2002 | WO2002056030A2 Method and device for collecting and stabilizing a biological sample |
| 07/18/2002 | WO2002056029A2 Occult blood test enhancer |
| 07/18/2002 | WO2002056028A2 Ingap displacement assays |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002056026A1 Novel proteome analysis method and devices therefor |
| 07/18/2002 | WO2002056025A2 Methods for systematic identification of protein - protein interactions |
| 07/18/2002 | WO2002056024A2 Detection methods |
| 07/18/2002 | WO2002056023A1 Optical sensor and sensor array |
| 07/18/2002 | WO2002056022A2 Diagnostics, drug screening and treatment for cancer |
| 07/18/2002 | WO2002056021A2 Polymer brushes for immobilizing molecules to a surface |
| 07/18/2002 | WO2002056020A1 Complexes of solid with polymer for biological assay |
| 07/18/2002 | WO2002056019A1 Test device |
| 07/18/2002 | WO2002056018A1 Surface chemical modification of optical elements |
| 07/18/2002 | WO2002056017A1 Lateral flow assay for detection of antibodies in human serum |
| 07/18/2002 | WO2002056016A2 Method for identifying a ligand for a biological substrate |
| 07/18/2002 | WO2002056015A1 Marker for inflammatory conditions |
| 07/18/2002 | WO2002056014A2 Methods for encoding and decoding complex mixtures in arrayed assays |
| 07/18/2002 | WO2002056013A2 Oxazolidinone photoaffinity probes, uses and compounds |
| 07/18/2002 | WO2002056012A1 Fluorescent analysis element with the use of metallic nanowell and process for producing the same |
| 07/18/2002 | WO2002056011A1 Selectively hybridizable substance immobilization fiber, fiber array compsiring bundle of such fibers, selective hybridizing method, device therefor, and base |
| 07/18/2002 | WO2002056010A2 Methods for the treatment of ibs |
| 07/18/2002 | WO2002056008A1 Determination of heteroatom content in fischer-tropsch wax |
| 07/18/2002 | WO2002056004A2 Thin film electrophoresis apparatus and method |
| 07/18/2002 | WO2002055996A1 Method for measuring the surface tension of an aqueous solution |
| 07/18/2002 | WO2002055995A2 Method and system for modeling cellular metabolism |
| 07/18/2002 | WO2002055992A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 07/18/2002 | WO2002055991A2 Tandem mass spectrometry of prostaglandin isomers |
| 07/18/2002 | WO2002055989A2 Stable isotope, site-specific mass tagging for protein identification |
| 07/18/2002 | WO2002055988A2 Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators |
| 07/18/2002 | WO2002055985A2 Methods and reagents for identifying rare fetal cells in the material circulation |
| 07/18/2002 | WO2002055742A2 Rapid method for screening compounds for in vivo activity |
| 07/18/2002 | WO2002055739A2 Nucleic acid extraction solution and use thereof |
| 07/18/2002 | WO2002055736A2 Antisense imaging of gene expression of the brain in vivo |
| 07/18/2002 | WO2002055735A2 Compositions and methods relating to prostate specific genes and proteins |
| 07/18/2002 | WO2002055734A1 A method and test kit for quantitative determination of variations in polynucleotide amounts in cell or tissue samples |
| 07/18/2002 | WO2002055733A2 Method for detecting living microorganisms |
| 07/18/2002 | WO2002055731A2 Dosage adjustement for antibiotics |
| 07/18/2002 | WO2002055728A2 Compositions and methods for regulating receptor clustering |
| 07/18/2002 | WO2002055720A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 07/18/2002 | WO2002055718A2 Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055704A2 Proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055697A2 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 07/18/2002 | WO2002055695A1 Human glioma antigen and process for preparing the same |
| 07/18/2002 | WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof |
| 07/18/2002 | WO2002055690A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/18/2002 | WO2002055680A2 Morphometric tissue or cell preparation |
| 07/18/2002 | WO2002055667A2 Identification of an advanced sleep phase syndrome gene in humans |
| 07/18/2002 | WO2002055665A2 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 07/18/2002 | WO2002055664A2 Modulating insulin receptor signaling |
| 07/18/2002 | WO2002055663A2 Srebp pathway modulation through targeting hisrs |
| 07/18/2002 | WO2002055654A2 Immunosubtraction method for sample preparation for 2-dge |
| 07/18/2002 | WO2002055653A1 Device for measuring extracellular potential, method of measuring extracellular potential by using the same and apparatus for quickly screening drug provided therewith |
| 07/18/2002 | WO2002055561A1 Method for surface display of proteins on genetic carriers |
| 07/18/2002 | WO2002055560A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | WO2002055556A2 Regulation of human voltage gated potassium channel protein kv2.2 |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055552A2 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055502A1 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 07/18/2002 | WO2002055199A2 Method and apparatus for delivery of submicroliter volumes onto a substrate |
| 07/18/2002 | WO2002055189A2 Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics |
| 07/18/2002 | WO2002055186A2 Surface modified semiconductive and metallic nanoparticlse having enhanced dispersibility in aqueous media |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055099A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | WO2002055089A2 Immunoassay technique using multispecific molecules |
| 07/18/2002 | WO2002055026A2 Perfluoro sulfonyl halides and related species as polymer support modifiers |
| 07/18/2002 | WO2002055019A2 Methods for ameliorating childhood infections |
| 07/18/2002 | WO2002055008A2 Meter strip dispenser assembly |
| 07/18/2002 | WO2002054969A1 System for growth, analysis, storage, validation and distribution of cells and tissues used for biomedical purposes |
| 07/18/2002 | WO2002054856A1 Chemical inhibitors of mismatch repair |
| 07/18/2002 | WO2002044422A8 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 07/18/2002 | WO2002039949A3 Platelet/leukocyte interaction assay and reagent therefor |